P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.

MLA

Aniket Bhide, et al. “P454: Acute Myeloid Leukemia (Aml) with Idh1 and Idh2 Mutations Can Be Effectively Risk Stratified Based on the Presence Adverse Risk Genomic Features.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000968724.09323.c5.

APA

Aniket Bhide, Gaurav Chatterjee, Sweta Rajpal, Swapnali Joshi, Vishram Terse, Dhanlaxmi Shetty, Anant Gokarn, Sachin Punatar, Nishant Jindal, Bhausaheb Bagal, Lingaraj Nayak, Hasmukh Jain, Navin Khattry, Manju Sengar, Prashant Tembhare, Sumeet Gujral, Papagudi Subramanian, & Nikhil Patkar. (2023). P454: Acute Myeloid Leukemia (Aml) with Idh1 and Idh2 Mutations Can Be Effectively Risk Stratified Based on the Presence Adverse Risk Genomic Features. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000968724.09323.c5

Chicago

Aniket Bhide, Gaurav Chatterjee, Sweta Rajpal, Swapnali Joshi, Vishram Terse, Dhanlaxmi Shetty, Anant Gokarn, et al. 2023. “P454: Acute Myeloid Leukemia (Aml) with Idh1 and Idh2 Mutations Can Be Effectively Risk Stratified Based on the Presence Adverse Risk Genomic Features.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000968724.09323.c5.